|
|
||||||||
1 Section of Pulmonary
Diseases,
Connective tissue growth factor (CTGF) is a
newly described 38-kDa peptide mitogen for fibroblasts and a promoter
of connective tissue deposition in the skin. The
CTGF gene promotor
contains a transforming growth factor-
1 (TGF-
1) response element.
Because TGF-
1 expression is upregulated in several models of
fibroproliferative lung disease, we asked whether CTGF is also
upregulated in a murine lung fibrosis model and whether CTGF could
mediate some of the fibrogenic effects associated with TGF-
1. A
portion of the rat CTGF gene was
cloned and used to show that primary isolates of both murine and human
lung fibroblasts express CTGF mRNA in vitro. There was a greater than
twofold increase in CTGF expression in both human and murine lung
fibroblasts 2, 4, and 24 h after the addition of TGF-
1 in vitro. A
bleomycin-sensitive mouse strain (C57BL/6) and a bleomycin-resistant
mouse strain (BALB/c) were given bleomycin, a known lung fibrogenic
agent. CTGF mRNA expression was upregulated in the sensitive, but not
in the resistant, mouse strain after administration of bleomycin. In
vivo differences in the CTGF expression between the two mouse strains
were not due to an inherent inability of BALB/c lung fibroblasts to
respond to TGF-
1 because fibroblasts from untreated BALB/c mouse
lung upregulated their CTGF message when treated with TGF-
1 in
vitro. These data demonstrate that CTGF is expressed in lung
fibroblasts and may play a role in the pathogenesis of lung fibrosis.
transforming growth factor-
1; collagen; mice
This article has been cited by other articles:
![]() |
C. L. Fattman, F. Gambelli, G. Hoyle, B. R. Pitt, and L. A. Ortiz Epithelial expression of TIMP-1 does not alter sensitivity to bleomycin-induced lung injury in C57BL/6 mice Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L572 - L581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Wesselkamper, S. A. McDowell, M. Medvedovic, T. P. Dalton, H. S. Deshmukh, M. A. Sartor, L. M. Case, L. N. Henning, M. T. Borchers, C. R. Tomlinson, et al. The Role of Metallothionein in the Pathogenesis of Acute Lung Injury Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1186 - L1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Watts and M. A. Spiteri Connective tissue growth factor expression and induction by transforming growth factor-{beta} is abrogated by simvastatin via a Rho signaling mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1323 - L1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ogawa, W. M. Elliott, F. Hughes, T. J. Eichholtz, J. C. Hogg, and S. Hayashi Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L189 - L197. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chaqour, C. Whitbeck, J.-S. Han, E. Macarak, P. Horan, P. Chichester, and R. Levin Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E765 - E774. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuoka, T. Arai, M. Mori, S. Goya, H. Kida, H. Morishita, H. Fujiwara, I. Tachibana, T. Osaki, and S. Hayashi A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L103 - L112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoi, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, H. Makino, T. Suganami, K. Yahata, Y. Fujinaga, I. Tanaka, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis Am J Physiol Renal Physiol, May 1, 2002; 282(5): F933 - F942. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KOLB, P. J. MARGETTS, T. GALT, P. J. SIME, Z. XING, M. SCHMIDT, and J. GAULDIE Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Allen, R. A. Knight, C. A. Bloor, and M. A. Spiteri Enhanced Insulin-Like Growth Factor Binding Protein-Related Protein 2 (Connective Tissue Growth Factor) Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 693 - 700. [Abstract] [Full Text] |
||||
![]() |
D. A. Ricupero, D. C. Rishikof, P.-P. Kuang, C. F. Poliks, and R. H. Goldstein Regulation of connective tissue growth factor expression by prostaglandin E2 Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1165 - L1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. DUNCAN, K. S. FRAZIER, S. ABRAMSON, S. WILLIAMS, H. KLAPPER, X. HUANG, and G. R. GROTENDORST Connective tissue growth factor mediates transforming growth factor {beta}-induced collagen synthesis: down-regulation by cAMP FASEB J, October 1, 1999; 13(13): 1774 - 1786. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |